Immediate Response of Fasting Blood Glucose to CV12 Versus ST36 Electroacupuncture in Type 2 Diabetic Men: A Placebo-Controlled Randomized study.

Immediate Response of Fasting Blood Glucose to CV12 Versus ST36 Electroacupuncture in Type 2 Diabetic Men: A Placebo-Controlled Randomized Pilot Study

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR202010486385289

Enrollment

100

Registered

2020-10-19

Start date

2020-10-18

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes mellitus

Interventions

electroacupuncture at cv12

Placebo CV12

electroacupuncture on ST36

placepo ST36

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1) One hundred T2DM patients from both sexes with BMI < 30 kg/m2. 2) The age of participants will range from 40-50 years old.

Exclusion criteria

Exclusion criteria: 1) Alcoholic, smoker, hypertensive, and addicted patients. 2) Patients with pulmonary, renal, hepatic, and cardiac disorders. 3) Patients who administered any form of complementary or alternative therapies in the last 3 months.

Design outcomes

Primary

Measure	Time frame
the On Call plus blood glucose meter will be used to measure the FBG.	—

Secondary

Measure	Time frame
body mass index by weight and height scale	—

Countries

Egypt

Contacts

Public Contactal shaymaa shaaban

lecturer at faculty of physical therapy

alshaymaa.shaaban@pt.cu.edu.eg01033771553

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026